Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


17.10.2022

3 AJR Am J Roentgenol
1 Am J Gastroenterol
2 Biochem Biophys Res Commun
1 BMC Gastroenterol
2 Endoscopy
2 Eur J Pediatr
3 Gut
2 Hepatology
2 J Gastroenterol Hepatol
3 J Hepatol
2 J Pediatr
1 Minerva Gastroenterol (Torino)
1 Radiology
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. FETZER DT
    Reply to "Underdiagnosis of High-Risk Liver Diseases Leads to Inadequate Ultrasound Screening for Hepatocellular Carcinoma".
    AJR Am J Roentgenol. 2022 Oct 12:2. doi: 10.2214/AJR.22.28134.
    PubMed        

  2. KUO SE, Lin YJ, Wang JD
    Underdiagnosis of High-Risk Liver Diseases Leads to Inadequate Ultrasound Screening for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2022 Oct 12:1-2. doi: 10.2214/AJR.22.28079.
    PubMed        

  3. GIAN RK
    Editorial Comment: An Algorithm to Distinguish Between Hepatocellular Adenoma Subtypes on Gadoxetate Disodium-Enhanced MRI.
    AJR Am J Roentgenol. 2022 Oct 12. doi: 10.2214/AJR.22.28613.
    PubMed        


    Am J Gastroenterol

  4. CARUSO S, Miraglia R, Alonzo L, Farinella M, et al
    A Rare Portopulmonary Arteriovenous Fistula in a Cirrhotic Patient with Portal Hypertension and Inversion of Blood Flow after Liver Transplantation.
    Am J Gastroenterol. 2022 Oct 6. pii: 00000434-990000000-00541.
    PubMed        


    Biochem Biophys Res Commun

  5. TU H, Yin X, Wen J, Wu W, et al
    Glutaminase 1 blockade alleviates nonalcoholic steatohepatitis via promoting proline metabolism.
    Biochem Biophys Res Commun. 2022;634:1-9.
    PubMed         Abstract available

  6. ZHAO S, Liu X, Li L, Kong X, et al
    KIRA8 attenuates non-alcoholic steatohepatitis through inhibition of the IRE1alpha/XBP1 signalling pathway.
    Biochem Biophys Res Commun. 2022;632:158-164.
    PubMed         Abstract available


    BMC Gastroenterol

  7. QIU C, Xie S, Sun Y, Yu Y, et al
    Multi-parametric magnetic resonance imaging of liver regeneration in a standardized partial hepatectomy rat model.
    BMC Gastroenterol. 2022;22:430.
    PubMed         Abstract available


    Endoscopy

  8. HIJIOKA S, Sakamoto Y, Nagashio Y, Maruki Y, et al
    Troubleshooting for endoscopic ultrasound-guided hepaticogastrostomy stent migration: Additional stenting by the partial stent-in-stent method.
    Endoscopy. 2022 Oct 14. doi: 10.1055/a-1941-8357.
    PubMed        

  9. OHNO A, Fujimori N, Abe T, Nakamura M, et al
    Bile peritonitis after placement of a metallic stent in endoscopic ultrasound-guided hepaticogastrostomy: A pitfall and the rescue technique.
    Endoscopy. 2022 Oct 10. doi: 10.1055/a-1937-9781.
    PubMed        


    Eur J Pediatr

  10. WU B, Zhou Y, Tian X, Cai W, et al
    Diagnostic values of plasma matrix metalloproteinase-7, interleukin-8, and gamma-glutamyl transferase in biliary atresia.
    Eur J Pediatr. 2022 Sep 12. pii: 10.1007/s00431-022-04612.
    PubMed         Abstract available

  11. BALESTRA E, Traunero A, Barbi E
    Investigating the role of Vitamin D in NAFLD: is liver biopsy justifiable in children?
    Eur J Pediatr. 2022;181:3985.
    PubMed        


    Gut

  12. KASPER P, Lang S, Demir M, Steffen HM, et al
    Optimising the management of cardiovascular comorbidities in NAFLD patients: it's time to (re-) act!
    Gut. 2022;71:2365-2366.
    PubMed        

  13. BELLOMO G, Rainer C, Quaranta V, Astuti Y, et al
    Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis.
    Gut. 2022 Jan 12. pii: gutjnl-2021-325272. doi: 10.1136/gutjnl-2021-325272.
    PubMed         Abstract available

  14. DUFOUR JF, Marjot T, Becchetti C, Tilg H, et al
    COVID-19 and liver disease.
    Gut. 2022;71:2350-2362.
    PubMed         Abstract available


    Hepatology

  15. LAM YK, Yu J, Huang H, Ding X, et al
    TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk.
    Hepatology. 2022 Oct 11. doi: 10.1002/hep.32802.
    PubMed         Abstract available

  16. RAHAL HK, Tabibian JH, Issaka RB, Quezada S, et al
    Diversity, equity, and inclusion in gastroenterology and hepatology: A survey of where we stand.
    Hepatology. 2022 Oct 11. doi: 10.1002/hep.32757.
    PubMed         Abstract available


    J Gastroenterol Hepatol

  17. SARAIVA RO, Gamelas V, Canha MI, Carvalho D, et al
    Hepatobiliary and Pancreatic: An unusual cause of biliary obstruction.
    J Gastroenterol Hepatol. 2022 Oct 10. doi: 10.1111/jgh.16009.
    PubMed        

  18. HOU G, Xu W, Ding D, Tian T, et al
    Metabolome and Transcriptome Integration Reveals Metabolic Profile of Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2022 Oct 8. doi: 10.1111/jgh.16024.
    PubMed         Abstract available


    J Hepatol

  19. LI T, Lu Z
    Factor VIII as a potential predictor of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis.
    J Hepatol. 2022 Oct 11. pii: S0168-8278(22)03136.
    PubMed        

  20. PERICAS JM, Tacke F, Anstee QM, Di Prospero NA, et al
    Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and Cons.
    J Hepatol. 2022 Oct 7. pii: S0168-8278(22)03131.
    PubMed         Abstract available

  21. TSAI PC, Kuo HT, Hung CH, Tseng KC, et al
    Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
    J Hepatol. 2022 Oct 5. pii: S0168-8278(22)03129.
    PubMed         Abstract available


    J Pediatr

  22. PIASTRA M, Morena TC, Ferrari V, Staccioni M, et al
    Delayed Skin and Airway Injury Associated with Liquid Trichloroethylene.
    J Pediatr. 2022;249:115-116.
    PubMed        

  23. SALVI PS, Fawaz R, Cowles RA
    Comparing Serum Matrix Metalloproteinase-7 in Parenteral Nutrition-Associated Liver Disease and Biliary Atresia.
    J Pediatr. 2022 Jun 14. pii: S0022-3476(22)00547.
    PubMed         Abstract available


    Minerva Gastroenterol (Torino)

  24. NICOLOSI A, Gaia S, Risso A, Rosso C, et al
    Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma.
    Minerva Gastroenterol (Torino). 2022 Oct 12. pii: S2724-5985.21.03006.
    PubMed         Abstract available


    Radiology

  25. KITAO A, Matsui O, Zhang Y, Ogi T, et al
    Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
    Radiology. 2022 Oct 11:220531. doi: 10.1148/radiol.220531.
    PubMed         Abstract available


    Transplantation

  26. ZOU Z, Shang R, Zhou L, Du D, et al
    The Novel MyD88 Inhibitor TJ-M2010-5 Protects Against Hepatic Ischemia-reperfusion Injury by Suppressing Pyroptosis in Mice.
    Transplantation. 2022 Oct 12. pii: 00007890-990000000-00172.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: